Illumina’s third quarter results reflected stable year-over-year revenue and a notable beat on Wall Street’s profit ...

The ban, which has been in place since March 4 following President Trump's doubling of tariffs on China, is expected to be ...

China is set to ease restrictions on some Illumina products, giving the sequencing giant a partial reprieve. | China is set to ease restrictions on some Illumina products, giving the sequencing giant ...

However, the sequencing company said it remains on China’s unreliable entity list, and it is working toward a long-term ...

The CheckMate 8HW trial evaluated the efficacy of nivolumab–ipilimumab versus nivolumab monotherapy in patients with microsatellite instability-high or mismatch repair-deficient metastatic colorectal ...